1. Home
  2. CDT vs HSCS Comparison

CDT vs HSCS Comparison

Compare CDT & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CDT

Conduit Pharmaceuticals Inc.

HOLD

Current Price

$1.43

Market Cap

5.9M

Sector

Health Care

ML Signal

HOLD

Logo Heart Test Laboratories Inc.

HSCS

Heart Test Laboratories Inc.

N/A

Current Price

$1.81

Market Cap

6.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CDT
HSCS
Founded
2019
2007
Country
United States
United States
Employees
4
12
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
6.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CDT
HSCS
Price
$1.43
$1.81
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$8.00
AVG Volume (30 Days)
11.7M
37.7K
Earning Date
04-15-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.37
$1.63
52 Week High
$11.00
$6.47

Technical Indicators

Market Signals
Indicator
CDT
HSCS
Relative Strength Index (RSI) 55.75 40.52
Support Level $1.24 $1.73
Resistance Level $1.59 $2.18
Average True Range (ATR) 0.18 0.13
MACD 0.11 -0.01
Stochastic Oscillator 56.12 6.73

Price Performance

Historical Comparison
CDT
HSCS

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.

About HSCS Heart Test Laboratories Inc.

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

Share on Social Networks: